Many medical marijuana users in Canada pay a high price due to their prescriptions, because life insurance policies consider them smokers — no matter how they consume the drug. Earlier this summer, the Supreme Court of Canada ruled patients with legal prescriptions have the right to take marijuana in any form: including smoking it, using [...]
Vancouver, British Columbia--(Newsfile Corp. - May 14, 2015) - THC BioMed Intl Ltd. (CSE: THC) is pleased to announce it has entered into a binding letter agreement (the "Agreement") with Trans-Medica Ltd. ("Trans-Medica"), to provide consulting services and utilize Trans-Medica's proprietary Vertical Grow System for total consideration to THC of $500,000. Pursuant to the Agreement, [...]
Vancouver, British Columbia--(Newsfile Corp. - May 12, 2015) - Marapharm Ventures (CSE: MDM) is one of the latest new listings on the Canadian Securities Exchange. Marapharm Ventures has entered the medical marijuana space through the acquisition of Marapharm Inc. InvestmentPitch.com has produced a "video news alert" which provides a brief overview of the company. If [...]
"I could't even eat this morning," said medical marijuana patient Anne Genovy as she sat in the front row of audience seats in Vancouver's Federal Court on Thursday.
THC BioMed Intl Ltd (CSE: THC) is one of the latest new listings on the Canadian Securities Exchange. The company has two Licensed Producer applications being evaluated by Health Canada under the Marihuana for Medical Purposes Regulations, with one filed for each of the company's wholly-owned subsidiaries.
The free-for-all era of Canada's commercial medical marijuana industry is over as a new crop of growers try to woo scarce investment dollars in an increasingly competitive business, observers say. Boris Ziger, CEO of Matica Enterprises Inc., said the short-lived days of unbridled growth ended soon after last year's change in federal regulations that shifted [...]
A constitutional challenge of Canada’s new medical marijuana laws will hear from marijuana law experts from Holland, Israel and the U.S. when it begins Monday in Vancouver. The expert witnesses will include Robert Mikos, a law professor at Vanderbilt University in Nashville; Dr. Yehuda Baruch, the former head of Israel’s Medical Use of Cannabis Program; [...]
Health Canada expects to spend more than $2 million this year to review applications from companies vying for entry into the commercial medical marijuana market, some of them having burned through millions of dollars trying to navigate a process that insiders say is mired in red tape.
Bab, Itai (2011). Themed Issue On Cannabinoids In Biology And Medicine. Br J Pharmacol 163: 1327-1328. DOI: 10.1111/j.1476-5381.2011.01536.x. Click to read full article Lynch ME, Campbell F (2011). Cannabinoids For Treatment Of Chronic Non-Cancer Pain; A Systematic Review Of Randomized Trials. Br J Clin Pharmacol DOI: 10.1111/j.1365-2125.2011.03970.x. Click to read full article Juurlink, David N, [...]